Role of albiglutide in the treatment of type 2 diabetes

    loading  Checking for direct PDF access through Ovid

Abstract

Albiglutide (Eperzan) is a GLP-1 agonist licensed for the treatment of type 2 diabetes in adults to improve glycaemic control. This article discusses its indications, efficacy and adverse effects.

Related Topics

    loading  Loading Related Articles